Valuation: Seegene, Inc.

Market Cap 1,337B 874M 764M 702M 654M 1.24B 83.17B 1.26B 8.43B 3.28B 40.88B 3.28B 3.21B 141B P/E 2026 *
16.6x
P/E 2027 * 14.2x
Enterprise Value 1,337B 874M 764M 702M 654M 1.24B 83.17B 1.26B 8.43B 3.28B 40.88B 3.28B 3.21B 141B EV / Sales 2026 *
2.52x
EV / Sales 2027 * 2.22x
Free-Float
59.55%
Yield 2026 *
3.75%
Yield 2027 * 4.05%
1 day+1.38%
1 week+0.69%
Current month-1.18%
1 month-7.85%
3 months+31.91%
6 months+20.04%
Current year+23.32%
1 week 27,850
Extreme 27850
31,450
1 month 26,350
Extreme 26350
32,000
Current year 21,700
Extreme 21700
32,500
1 year 21,700
Extreme 21700
33,200
3 years 19,040
Extreme 19040
36,650
5 years 19,040
Extreme 19040
94,700
10 years 7,225
Extreme 7225
161,100
Manager TitleAgeSince
Chief Executive Officer 69 2010-09-16
President 54 -
President 74 -
Director TitleAgeSince
Director/Board Member 69 2011-06-30
Chairman 79 -
Director/Board Member 74 -
Date Insider Type Main position Quantity % Market Cap.
24-05-29Sell

Executive/Senior Manager

4,201 0.0080%
24-05-29Sell

Executive/Senior Manager

191 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+1.38%+0.69%-10.93%+42.82% 856M
-4.63%-2.51%+106.96%+124.11% 4.55B
-5.27%+4.64%+84.58%+215.80% 3.39B
+2.15%+0.88%-25.09%-38.94% 2.03B
-9.51%+2.38%+146.29%-38.78% 1.92B
+1.25%+4.81%+49.77%+243.41% 1.51B
-1.79%-1.31%+127.92%-51.41% 891M
+2.32%+5.38%-34.20%-16.34% 486M
-0.83%-0.24%+1.82% - 473M
-3.10%-8.92% - - 196M
Average -0.14%-2.40%+49.68%+60.08% 1.63B
Weighted average by Cap. -1.15%-1.41%+72.53%+95.51%

Financials

2026 *2027 *
Net sales 531B 347M 303M 279M 260M 493M 33.02B 500M 3.35B 1.3B 16.23B 1.3B 1.27B 55.94B 603B 394M 345M 317M 295M 560M 37.53B 568M 3.8B 1.48B 18.45B 1.48B 1.45B 63.56B
Net income 92.2B 60.24M 52.66M 48.39M 45.11M 85.56M 5.74B 86.86M 581M 226M 2.82B 226M 221M 9.72B 108B 70.76M 61.85M 56.84M 52.99M 100M 6.74B 102M 682M 265M 3.31B 266M 260M 11.41B
Net Debt - -
Logo Seegene, Inc.
Seegene Inc is a Korea-based company engaged in the development, manufacturing and distribution of molecular diagnostic reagents. The Company mainly provides infectious pathogens inspection products, including allergic respiratory pathogens, sexually transmitted diseases pathogens, human papilloma virus (HPV) and other inspection products, drug resistance inspection products, single nucleotide polymorphisms (SNP) inspection products, as well as somatic mutation cancer inspection products. In addition, it is involved in the provision of automatic real-time detection instruments. The Company provides its products under the brand names of Seeplex, Anyplex and Magicplex. The Company distributes its products within domestic market and to overseas markets.
Employees
216
Date Price Change Volume
26-07-02 29,350.00 +1.38% 294,822
26-07-02 ₩28,950.00 +0.87% 166,162
26-07-01 ₩28,700.00 -3.37% 256,647
26-06-30 ₩29,700.00 -2.46% 217,379
26-06-29 ₩30,450.00 +8.75% 399,845
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
29,350.00KRW
Average target price
39,500.00KRW
Spread / Average Target
+34.58%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A096530 Stock